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No test is available that can identify all potential pathogens in acute respiratory tract infections. Each diagnostic test is 
associated with limitations with respect to sensitivity and/or specificity and/or speed, and thus a combination of tests 
has to be used. Even so, no etiologic agent is found in 30-60% of cases. The following methods are recommended for 
use in the routine laboratory for the diagnosis of infections: (1) Legionella - direct immunofluorescence test, culture, 
serology and antigen detection (available only in specialized laboratories); (2) Chlamydia pneumoniae - micro- 
immunofluorescence test, complement fixation, but not direct antigen detection by immunofluorescence; (3) 
Mycoplasma pneomoniae - complement fixation and/or particle agglutination or other evaluated methods; (4)  Coxiella 
burnetii- immunofluorescence test (IgG and IgM) and complement fixation; (5) viruses - complement fixation or other 
similar test (ELISAs often lack adequate evaluation). Culture for Chlamydia, Mycoplasma pneumoniae, Coxiella bornetii 
and viruses should only be performed by very experienced laboratories. Most procedures deliver results only 
retrospectively or too late. The most promising diagnostic tools for the future are nucleic acid amplification techniques 
(NAT) or PCR, which could solve many of the problems connected with conventional techniques, but there are enormous 
contamination problems. Further research and worldwide aid in the development of standardized NAT, especially by 
industrial companies, is urgently encouraged to improve the laboratory diagnosis of these pneumonias. 
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The microbiological diagnosis of acute community- 
acquired respiratory tract infection cannot rely on 
culture alone. For many potential pathogens, such as 
Legionella, Chlamydia pneumoniae, Mycoplasma pneu- 
moniae and viral pneumonias, culture has either a low 
sensitivity and/or is time-consuming. Therefore, other 
methods for antibody and antigen detection, as well as 
nucleic acid amplification techniques (NAT), have 
been developed in order to improve sensitivity and 
detection time. 
LEGIONELLA 
Besides Legionella pneumophila (serogroup l), con- 
stituting more than two-thirds of all Legionella-caused 
infections, L. micdadei, L. longbeachae, L. gormanii, L. 
dumofi and L. bozemanii are also isolated from patients 
with legionellosis [1,2]. Culture has a specificity of 
loo%, but a sensitivity of 50-80%, and growth is 
detectable only after 2 to 10 days. Currently, four 
additional methods are therefore used for the laboratory 
diagnosis of legionellosis. 
1. Serodiagnosis. This involves determination of 
antibody levels by immunofluorescence. A fourfold rise 
against L. pneumophila serogroup 1 (seroconversion) is 
diagnostic. Formalin-fixed, heat-killed L. pneumophila 
serogroup 1 is recommended as the most specific test 
antigen, but has a sensitivity of only 60-80% [1,3]. To 
improve sensitivity, a pool of Legionella antigens may 
be used for screening purposes. Too many antigens used 
as test antigens, however, decrease sensitivity and 
specificity. Therefore, not more than four to six 
antigens should be included [4]. In the case of a positive 
result, single Legionella antigens have to be tested 
additionally because of cross-reactivity of the pool with 
other bacteria, e.g. Aeudomonas, Haemophilus, Bacteroides, 
Campylobacter spp. and many others [3]. An antibody 
rise is observed after an average of 2 to 3 weeks. The 
main drawback of antibody testing is that serocon- 
version may take up to 9 weeks (1 to 9 weeks) after 
onset of infection, and life-threatening L. pneumonia 
not be recognized. Thus serodiagnosis is usually retro- 
spective and cannot substitute €or culture. A single titer 
of > 1:256 is diagnostic only in the face of an outbreak, 
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but is not diagnostic in a non-outbreak setting [5]. 
ELISA and microagglutination methods can also be 
used but are not commercially available. 
2. Direct immunojuorescence (DFA). This has poor 
sensitivity (25%, up to 70%) [3], and the detection limit 
is lo4 to lo5 bacteria/mL. Specificity is 95'36, if genus- 
specific monoclonal antibodies are used directed against 
all serogroups of L. pneumophila (Genetic Systems, 
Seattle, Washington) and if sufficient skill is used in 
reading DFA test slides. The other Legionella species, 
however, are not detected by these antibodies. 
3. D N A  probes. Various studies showed a sensi- 
tivity of approximately 50% [l] and very different 
specificities between 43% [5] and 99% [I] ,  if applied 
to clinical specimens. Thus probe assays do not seem 
to be applicable for routine use with clinical speci- 
mens. 
4. Urinury antigen. Sensitivities between 50%) [2] 
and 99% and specificities from 40% up to 99% have 
been reported [1,6], depending on which test system 
and which antibody was used. A commercially available 
KIA test kit (Binax, South Portland, ME) showed a 
specificity of 99% and a sensitivity of 80% in cases in 
which L. pneumophila serogroup 1 was isolated [2]. This 
RIA antigen-detection system was recommended to be 
included as a diagnostic criterion for Legionnaire's 
disease, but drawbacks include the limitation to a single 
serogroup and the need for radiolabeled reagents with 
a short shelf life. Enzyme imniunoassays and latex 
agglutination assays are either not commercially avail- 
able or lack specificity and sensitivity. Antigenuria may 
last up to 1 year [7]. 
All methods currently available lack either sensitivity or 
specificity and have to be used in combination as far as 
these methods are available. Culture is the preferred 
diagnostic method. 
Definition for legionellosis include (1) pneumonia 
plus (2) a culture positive for Legionella and/or (3) a 
fourfold rise of Legionella antibody titer (8) and/or, as 
previously proposed, (4) a positive urinary antigen assay 
121, provided a specific test system is used. 
Polymerase chain reaction (PCR) methods applied 
to clinical specimens are currently under investigation. 
Only a few studies have been performed, with too few 
patients. The value of this method has not been proven 
yet. 
CHLAMYDIA PNEUMONIAE 
Cultural isolation of C. pneumoniae has been hampered 
by very low sensitivity and tedious subculture procedures 
191. Further methods to be used include the following: 
1. Techniques of direct antigen detection, e.g. in 
sputum, which lack specificity and sensitivity. There- 
fore diagnosis has to be relied on. 
2. Serodiagnosis using microimmunojuorescencr methods. 
A fourfold rise in serologic titer or a single IgG 
antibody titer 21:526 or an IgM antibody titer 21:32 
using C. pneumoniae antigen (Washington Research 
Foundation) are considered to be of diagnostic rele- 
vance [9-111. Sensitivity is reported to range between 
70% and 90%, and specificity between 90% and 99%, 
though lower specificities are reported, depending on 
the experience of the examiner. Cross-reactions with 
C. trachomatis and C. psittaci are described [121 which 
have to be tested in parallel with C. pneumoniae. The 
IgM response appears about 3 weeks and the IgG 
responses about 1 to 10 weeks (on average 6 to 8 weeks) 
after the onset of illness, while in reinfection only an 
IgG response occurs, usually within 1 to 2 weeks [lo]. 
The value of a single elevated IgG antibody titer is 
considered as doubtful by some authors, because of a 
calculation of 20% false positives in asymptomatic 
individuals [12]. But false positives only occur if the 
upper detection limit of antibody titer is not defined 
correctly. Each examiner has to adapt his or her test 
system individually (Grayston, personal communi- 
cation). The 97-99% upper detection limit of non- 
Chlamydia-infected or asymptomatic control groups has 
to be defined before evaluating the test in a group of 
patients suspected to be infected with C. pneumoniae. 
Many laboratories use complement-fixation (CF) 
tests as an alternative, with genus-specific heat-stable 
lipopolysaccharide antigens. A fourfold rise or a single 
acute titer of 21:64 is considered to be of diagnostic 
importance. The CF  test does not distinguish between 
Chlamydia species, and the sensitivity is lower (below 
50%) than that of the microimmunofluorescence test. 
Cross-reactions occur with other bacteria. Because of 
the delayed antibody response it is not sufficient to 
examine a second serum specimen after 2 weeks. If 
diagnosis remains unclear, it is recommended to test a 
third serum specimen, e.g. 6 to 8 weeks after the second 
specimen. 
In summary, serologic diagnosis of C. pneumoniae 
is difficult and needs highly skilled personnel. 
3. PCK applied to nasopharyngeal specimens may 
be more reliable for the diagnosis of acute C. pneu- 
moniae infection than positive serology. In one study, 
P C R  resulted in a sensitivity of 76% and a specificity 
of 99% in comparison with a successfully performed 
culture [13]. The development of not yet standardized 
NATs is of the utmost importance for the diagnosis of 
C. pneumoniae infection. 
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Culture results are seldom positive and require 1 to 3 
weeks (sensitivity 20-64%). Because of better sensiti- 
vity, the diagnosis is commonly based on the following: 
1. Serology using CF or particle agglutination test 
of paired sera, which takes 1 to 3 weeks to complete. 
Though the glycolipid-containing crude antigen 
extract used in the CF test is not a M. pneurnoniae- 
specific antigen, a high degree of suspicion for a M. 
pneurnoniae infection is associated with CF  titers 2 1:64 
with a sensitivity of 80-90% and a specificity of 95%, 
if the clinical picture is taken into consideration. The 
diagnostic value of the CF test and the agglutination 
test may be limited because of false-positive results [14] 
and also because titers may remain elevated for a 
considerable time, e.g. up to 5 to 9 years (on average 2 
to 3 years), though we observed a decline of CF 
antibodies after 2 to 6 months (unpublished obser- 
vations). Specific IgM antibody responses are reported 
to be diagnostically useful but may be lacking in 
secondary infections. 
2. Cold hemagglutinins, directed against erythro- 
cyte i antigens, develop in 30-70% of patients (second 
to third week), and are diagnostically useful if a M .  
pneurnoniae infection is suspected clinically. 
3.  DNA probes do not seem to be sufficiently 
sensitive. 
4. Rapid antigen testing in nasopharyngeal se- 
cretions using monoclonal antibodies seems promising 
NATs, e.g. PCR, are still in the experimental stage. 
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C U X / W d  BURNFT// (Q FEVER) 
Though Coxiella burnetii can be easily isolated by 
culture from buftt-coat samples and biopsy specimens, 
serology is the most convenient and most commonly 
used diagnostic tool [16]. Two methods are recom- 
mended: (1) CF, which is highly specific but lacks 
sensitivity (60-80%) [16,17]; and (2) IgM and IgG 
indirect immunofluorescence (IFA) against phase I 
(chronic infections) and phase I1 antigens (acute 
infection). This is the reference method [16,18] with 
sensitivities above 90% [17]. CF  antigen can be used to 
perform IFA. An elevated IgM titer is diagnostic for an 
acute infection [16]. 
VIRAL PNEUMONIAS 
Lower respiratory tract viral disease in adults caused by 
respiratory syncytial virus (RSV), adenovirus, influenza 
or parainffuenza virus are diagnosed by three procedures. 
1. Cultures are not useful in the initial evaluation 
of patients with community-acquired pneumonia and 
should not be routinely performed [I91 (overall sensi- 
tivity 40-60%; but false-positive cultures occur in 
asymptomatic patients). 
2. Viral antigen detection in respiratory secretions 
(by IFA, monoclonal antibodies, ELISA, shell vial 
techniques) after the acute phase. 
3.  Serologic tests of a number of types (fourfold 
rise in titer). A single elevated titer is much less specific. 
IgM antibody testing is less sensitive. 
Pneumonia as part of a systemic viral infection 
such as measles or varicella-zoster, or Epstein-Barr 
virus (EBV) and cytomegalovirus (CMV) (antigen test- 
ing, histology, PCR)  are more easily recognized by 
serologic procedures, except for patients with im- 
niunodeficiency syndrome. 
Hantavirus pneumonia is often diagnosed retro- 
spectively by seroconversion, immunohistochemistry 
or PCR in specialized laboratories. 
PNEUMOCOCCAL DISEASE 
Antigen detection in serum, urine or sputum for the 
diagnosis of pneumococcal disease [20-221 is not 
sufficiently sensitive or specific and results in low 
predictive values. 
NUCLEIC ACID AMPLIFICATION TECHNIQUES 
(NAT) - POLYMERASE CHAIN REACTION (PCR) 
NATs are very promising with respect to sensitivity and 
microbiological specificity, but problems of 'technical' 
specificity (contamination) are not resolved. Unfor- 
tunately, there are no tests commercially available for 
routine use. Even for the experimentally designed 
'house-made' tests, very few clinical studies and no 
prospective studies have been performed until now. 
Many other problems are not yet settled, such as 
standardization of DNA isolation and sample pre- 
paration, avoidance of inhibition, definitions of indica- 
tions for performing NATs and external quality control. 
It should be kept in mind that no method besides 
culture is 100% specific. Therefore, in areas where 
disease is rare (e.g. less than 1% of patients tested), the 
predictive values are low, resulting in a more pre- 
sumptive diagnosis and in more false-positive results. 
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